°ÅÀÖÊÓÆµ

Read about upcoming changes to coverage.

Richard R. Furman, M.D.

Medical Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Medicare
Specialties
Medical Oncology
Hematology
Biographical Info

Dr. Furman is Director of the CLL Research Center at °ÅÀÖÊÓÆµ and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology.  His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.

For More Videos, please see below:

Honors and Awards

Charles, Lillian and Betty Neuwirth °ÅÀÖÊÓÆµ Scholar Award, 2004-2006

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
°ÅÀÖÊÓÆµ Expertise
CLL (Chronic Lymphocytic Leukemia)
Chronic Lymphocytic Leukemia
Waldenstrom's Macroglobulinemia
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Leukemia
Idiopathic Thrombocytopenic Purpura
Education 
  • M.D.
    Mount Sinai School of Medicine
    1993
Appointments 
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Morton Coleman, M.D. Distinguished Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Associate Attending Physician
    NewYork-Presbyterian Hospital
Research
Videos

Lymphoma Program | °ÅÀÖÊÓÆµ

Richard Furman, M.D.

We Are °ÅÀÖÊÓÆµ | Dr. Babacar Cisse

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, °ÅÀÖÊÓÆµ physicians and scientists are sought after by many organizations to consult and educate. °ÅÀÖÊÓÆµ and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member: 
AbbVie Inc.
AstraZeneca Pharmaceuticals LP
BeiGene USA
Eli Lilly and Company
Genentech, Inc.
Sanofi S.A.
Speaker/Lecturer: 
BeiGene USA
Other Interest: 
Secura Bio, Inc.